H.(T.) v. Novartis Pharm. Corp., No. S233898, -- P.3d --, 2016 WL 3192406 (Cal. June 8, 2016)
On two consecutive days, two different federal juries returned defense verdicts in favor of Firm client Novartis Pharmaceuticals Corporation in trials arising out of the federal MDL litigation pending in the Middle District of Tennessee, In re…
After less than five hours of deliberation, a Brooklyn, New York federal jury on May 25, 2011, returned a verdict in favor of Novartis Pharmaceuticals Corporation in a seven-day trial involving Aredia® and Zometa®, bisphosphonate drugs…
The United States District Court for the Middle District of Tennessee today granted Novartis Pharmaceutical Corporation’s motion for summary judgment in Foster v. Novartis Pharmaceuticals Corp., 3:08-0932 (M.D. Tenn.). Mr. Foster alleged that his wife’s use…
After two hours of deliberation, a New Brunswick, New Jersey jury on October 6, 2010, returned a 7-2 verdict in favor of Novartis Pharmaceuticals Corporation in a ten-day trial involving Aredia® and Zometa®, bisphosphonate drugs given…
In September 2010, the U.S. Court of Appeals for the Sixth Circuit reversed a $20.5 million jury verdict in favor of a plaintiff in the welding fume litigation, holding that the district court had abused its…
Judge Jessica Mayer, Mass Tort Judge for the New Jersey Superior Court in Middlesex County, granted summary judgment in favor of Firm client Novartis Pharmaceuticals Corporation (“NPC”) and dismissed a case brought by a Canadian plaintiff…
On April 1, 2010, Judge Jessica Mayer, Mass Tort Judge for the New Jersey Superior Court in Middlesex County, granted firm client Novartis Pharmaceutical Corporation summary judgment in Walsh v. Novartis Pharmaceutical Corporation. Click here to view opinion. Plaintiff…
On April 1, 2010, Judge Jessica Mayer, Mass Tort Judge for the New Jersey Superior Court in Middlesex County, granted firm client Novartis Pharmaceutical Corporation’s motion to exclude the testimony of plaintiff’s case-specific expert Dr. Joseph…
On November 24, 2009, the United State Court of Appeals for the Sixth Circuit affirmed the grant of summary judgment in favor of firm client Novartis Pharmaceuticals Corporation in three cases brought by residents of Michigan…
On November 24, 2009, the United State Court of Appeals for the Sixth Circuit affirmed the grant of summary judgment in favor of Firm client Novartis Pharmaceuticals Corporation (“NPC”) in five cases brought by plaintiffs who…
On November 23, 2009, Judge Mayer of New Jersey Superior Court held that New Jersey law governing punitive damages would apply to two of the Aredia® and Zometa® cases currently being worked up for trial. Firm…
Case No. 3:08-1157, Anderson. In the first wave of cases in the In re Aredia and Zometa Products Liability Litigation, Chief Judge Todd Campbell of the United States District Court for the Middle District of Tennessee granted summary…
In the first wave of cases in the In re Aredia and Zometa Products Liability Litigation, Chief Judge Todd Campbell of the United States District Court for the Middle District of Tennessee granted summary judgment for firm…
On March 4, 2009, the Supreme Court ruled 6-3 that plaintiff Diana Levine could sue the drugmaker Wyeth for injuries she suffered after receiving the antinausea drug Phenergan. Click here to view the opinion. The medicine…
On December 2, 2008, Chief Judge Todd J. Campbell of the United States District Court for the Middle District of Tennessee granted summary judgment to Firm client, Novartis Pharmaceuticals Corporation (NPC), in five lawsuits brought by…
On December 3, 2008, the federal Judicial Panel on Multidistrict Litigation issued an order transferring two actions pending against a Firm client, Novartis Pharmaceuticals Corporation (NPC), back to the Aredia®/Zometa® MDL over the objections of the…
On September 29, 2008, Chief Judge Todd J. Campbell of the United States District Court for the Middle District of Tennessee granted summary judgment to Firm client, Novartis Pharmaceuticals Corporation (NPC), in a lawsuit alleging that…
On July 22, 2008, the Philadelphia County Court of Common Pleas granted C.R. Bard, Inc.’s (“Bard”) Motion to Dismiss Pursuant to Forum Non Conveniens and 42 Pa. C.S.A. § 5322(e) in the case of Murphy v. C.R. Bard, Inc.…
On August 16, 2007, the United States District Court for the District of New Jersey denied plaintiff’s motion to remand in Ripley v. Sandoz, Inc., finding removal to be proper under 28 U.S.C. Sec. 1441(b) despite…
On July 26, 2007, the Court of Appeals for the First District of Texas (Houston) issued a major opinion confirming the requirement of science-based evidence of specific causation in asbestos bodily injury claims. Georgia-Pacific Corp. v. Stephens,…
In a 4-3 ruling, the Missouri Supreme Court rejected a public nuisance claim brought against former lead paint manufacturers by the City of St. Louis, holding that the City’s inability to identify the defendants that supplied…
In 2005, the U.S. Court of Appeals for the Eleventh Circuit issued its opinion vacating the judgment of the trial court and erasing an $18 million lost profits award against the Firm’s client, General Electric. GE…
The National Law Journal selected Hollingsworth LLP three times in seven years for its Top Ten Defense Wins list, including for its success in Crowson v. Davol, a major medical device trial in 2004. This complex…
The U.S. Court of Appeals for the Eleventh Circuit unanimously affirmed the grant of summary judgment to client, Novartis Pharmaceuticals in Rider/Siharath v. Sandoz Pharm. Corp., 131 F. Supp. 2d 1347 (N.D. Ga. 2001). This decision…
In March 2000, the U.S. District Court for the Western District of Oklahoma entered summary judgment for Sandoz Pharmaceuticals Corporation, holding that the plaintiff’s proffered expert testimony that Parlodel® caused her stroke was not scientifically reliable…
Following a two-day evidentiary Daubert hearing in Caraker v. Sandoz Pharm. Corp., 172 F. Supp. 2d 1046 (S.D. Ill. 2001), Judge J. Phil Gilbert granted Firm client Sandoz’s motion to exclude expert testimony of plaintiffs’ expert witnesses…
March 19, 2001by Emily Heller For litigators who defend, winning summary judgment is about as good as it gets. To many, it’s even more satisfying than a favorable jury verdict because it avoids the expense and…